- Home
- IMNM vs MNRO Comparison
IMNM vs MNRO Comparison
Compare IMNM & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- MNRO
- Stock Information
- Founded
- IMNM 2006
- MNRO 1957
- Country
- IMNM United States
- MNRO United States
- Employees
- IMNM N/A
- MNRO N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- MNRO Automotive Aftermarket
- Sector
- IMNM Health Care
- MNRO Consumer Discretionary
- Exchange
- IMNM Nasdaq
- MNRO Nasdaq
- Market Cap
- IMNM 806.1M
- MNRO 658.9M
- IPO Year
- IMNM 2020
- MNRO 1991
- Fundamental
- Price
- IMNM $9.52
- MNRO $18.71
- Analyst Decision
- IMNM Strong Buy
- MNRO Hold
- Analyst Count
- IMNM 5
- MNRO 2
- Target Price
- IMNM $28.60
- MNRO $25.50
- AVG Volume (30 Days)
- IMNM 1.2M
- MNRO 956.1K
- Earning Date
- IMNM 03-27-2025
- MNRO 01-29-2025
- Dividend Yield
- IMNM N/A
- MNRO 5.99%
- EPS Growth
- IMNM N/A
- MNRO N/A
- EPS
- IMNM N/A
- MNRO 0.62
- Revenue
- IMNM $10,129,000.00
- MNRO $1,210,419,000.00
- Revenue This Year
- IMNM N/A
- MNRO N/A
- Revenue Next Year
- IMNM N/A
- MNRO $2.64
- P/E Ratio
- IMNM N/A
- MNRO $30.34
- Revenue Growth
- IMNM N/A
- MNRO N/A
- 52 Week Low
- IMNM $8.97
- MNRO $18.29
- 52 Week High
- IMNM $30.96
- MNRO $33.98
- Technical
- Relative Strength Index (RSI)
- IMNM 40.66
- MNRO 33.04
- Support Level
- IMNM $9.67
- MNRO $18.74
- Resistance Level
- IMNM $10.68
- MNRO $19.92
- Average True Range (ATR)
- IMNM 0.80
- MNRO 0.70
- MACD
- IMNM -0.08
- MNRO 0.14
- Stochastic Oscillator
- IMNM 0.34
- MNRO 22.70
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About MNRO Monro Inc.
Monro Inc is a provider automobile service stations in the United States. Through its network of company-owned service stations, Monro Muffler Brake offers maintenance, repair, tire, and fleet management services for automobiles focused largely on undercar services such as brake, steering, exhaust, drivetrain, and suspension systems. Next to service stores, the company also offers tire stores specialised in tire replacement and service.